Aeterna Zentaris Inc.(Toronto Stock Exchange : AEZS)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 0.55% | 73.74 | 0.9% | $598.99m | |
| CELG | Celgene Corporation | -0.84% | 129.19 | 1.1% | $425.21m | |
| AMGN | Amgen Inc. | -0.63% | 169.00 | 1.1% | $397.19m | |
| BIIB | Biogen Inc. | -1.42% | 282.64 | 1.2% | $346.45m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.31% | 477.15 | 2.7% | $319.17m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.43% | 153.25 | 1.9% | $227.49m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.83% | 135.67 | 1.9% | $211.59m | |
| ILMN | Illumina, Inc. | -0.59% | 193.62 | 3.5% | $208.34m | |
| KITE | Kite Pharma, Inc. | 1.63% | 138.17 | 16.1% | $135.10m | |
| INCY | Incyte Corporation | -0.17% | 123.65 | 2.6% | $130.04m | |
| CLVS | Clovis Oncology, Inc. | -0.68% | 71.61 | 18.0% | $125.25m | |
| TSRO | TESARO, Inc. | -0.18% | 120.40 | 14.7% | $124.85m | |
| A | Agilent Technologies, Inc. | -0.30% | 62.77 | 1.5% | $122.45m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.07% | 81.40 | 4.4% | $105.16m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.38% | 36.07 | 19.8% | $88.80m |
Company Profile
Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company that is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. The company's pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products. It focuses on the development of Perifosine, Cetrotide, Ozarelix, AEZS-108 and AEZS-130. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Montreal, Canada.